tirzepatide diabetes trial

tirzepatide diabetes trial monotherapy in Chinese patients with early type 2 diabetes: A randomized, double-blind, placebo-controlled phase 3 (SURPASS-CN-MONO) Adding tirzepatide to basal insulin

Name: tirzepatide diabetes trial monotherapy in Chinese patients with early type 2 diabetes: A randomized, double-blind, placebo-controlled phase 3 (SURPASS-CN-MONO) Adding tirzepatide to basal insulin
Brand: actil.am
SKU: 45835065755
Price: 20.76 USD
Availability: InStock
Rating: 4.2106 (11 reviews)

SKU: 45835065755

4.2

USD20.76 USD55.76

Pay in 4 interest-free payments of $5.19 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 27 - Sep 1

Description

Community reports put the prevalence at roughly 10 to 15 percent, almost always tied to evening injection timing

42 , W401W407 (2014)

Policymakers and pharmaceutical companies may need to explore subsidy programs, generic alternatives, or broader insurance support to improve affordability